Insmed

INSMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$28.416 B

$131.10 -1.09%

Close of 7 Aug 2026

Revenue

$606.4M

#1817 by revenue

Earnings

-$1.28B

Loss-making

Shares outstanding

218,381,503

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#19ZoetisZTS$30.5B
#20Alnylam PharmaceuticalsALNY$29.3B
#21InsmedINSM$28.4B
#22Roivant SciencesROIV$26.3B
#23United TherapeuticsUTHR$23.1B

Where these numbers come from

Share counts and financials for Insmed are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.